Atellica® CH Diazo Total Bilirubin (D_TBil)— 510(k) K222104

Substantially Equivalent

Siemens Healthcare Diagnostics, Inc.

FDA 510(k) clearance K222104 for Atellica® CH Diazo Total Bilirubin (D_TBil), Substantially Equivalent on 2023-03-20. Applicant: Siemens Healthcare Diagnostics, Inc..

Clearance details

Applicant
Siemens Healthcare Diagnostics, Inc.
Product code
Code CIG
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Newark, DE, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.